EZZ Life Science Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

ASX:EZZ Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
11 Dec 24	BuyAU$246,149	Mark Qin	Individual		90,830	AU$2.71

Insider Trading Volume

Insider Buying: EZZ insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of EZZ?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	561,009	1.22%
General Public	12,351,253	26.8%
Individual Insiders	16,229,938	35.2%
Public Companies	17,016,000	36.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 8.1%.

Top Shareholders

Top 17 shareholders own 73.24% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
36.9%	Macquarie Group Limited	17,016,000	AU$49.5m	0%	no data
26.9%	Mark Qin	12,434,830	AU$36.2m	9.62%	no data
3.81%	Yong Cao	1,760,000	AU$5.1m	0%	no data
1.05%	Zhaoying Wang	486,000	AU$1.4m	0%	no data
1.02%	Haitao Zheng	470,000	AU$1.4m	-2.08%	no data
0.88%	Mars Family Investment Pty Ltd	405,000	AU$1.2m	-15.6%	no data
0.72%	Jing Chen	331,980	AU$966.1k	-30.8%	no data
0.56%	Oren Danziger	256,606	AU$746.7k	0%	no data
0.34%	Pershing Securities Australia Pty. Ltd.	156,009	AU$454.0k	0%	no data
0.32%	Xiaojing Wang	150,000	AU$436.5k	0%	no data
0.25%	Emma Sievwright	115,688	AU$336.6k	0%	no data
0.24%	Stephen Mander	113,040	AU$329.0k	-5.83%	no data
0.097%	Glenn Cross	45,000	AU$130.9k	12.5%	no data
0.056%	Ivan Oshry	26,000	AU$75.7k	23.8%	no data
0.056%	Zhang Qingyuan	26,000	AU$75.7k	0%	no data
0.021%	Anthony Guarna	9,794	AU$28.5k	0%	no data
0.011%	Lily Huang	5,000	AU$14.5k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/21 02:54
End of Day Share Price	2024/12/20 00:00
Earnings	2024/06/30
Annual Earnings	2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

EZZ Life Science Holdings Limited is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
null null	Lodge Partners Pty Ltd.
Chris Kallos	MST Financial Services Pty Limited